Advance your life-saving molecule from non-clinical to clinical with speed and agility

With patients’ lives on the line, you cannot afford any mistakes within your drug development program. That’s why finding the right bioanalytical lab to get you accurate and timely data will help you successfully file your IND with speed and confidence. We are committed to ensuring that your drug program is scientifically and regulatory compliant across all phases.

Aliri offers leading science, rapid response, and regulatory leadership.

Navigating a robust regulatory environment, advancing your development program with speed, and accessing a breadth of technical expertise are all critical factors to the success of your program. Aliri provides a range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions to support the bioanalytical lifecycle of your drug. By selecting us as your partner, you gain access to a full range of bioanalytical services that is backed by a network of seasoned scientists, program managers, and technical experts.

Our proficiency with more than 1,500 drugs and metabolites and more than 150 types of biological specimens assures expertise on all types of programs, such as small and large molecules and gene therapies.

Aliri provides a range of bioanalytical lab and bioanalysis imaging solutions.

Our wide selection of non-proprietary assays (NPAs) will help advance your molecule and drug development strategy with ease. Explore our comprehensive list of NPAs currently available.

Areas of expertise:


Discovery PK/ bioavailability: RAPID turnaround




GLP pre-clinical and non-clinical studies: IND-enabling studies


Clinical studies performed under GCP


Post marketing surveillance


Veterinary medicine drug development: FDA CVM


Biomarkers: fit for purpose – non- GLP and GLP


Drugs & Metabolites Experiences


FDA Audits


Samples Analyzed

Ready to discuss your bioanalytical project?